PetMed Express (PETS)
(Delayed Data from NSDQ)
$4.05 USD
-0.08 (-1.94%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $4.06 +0.01 (0.25%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Price, Consensus and EPS Surprise
PETS 4.05 -0.08(-1.94%)
Will PETS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PETS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PETS
PetMed (PETS) Reports Break-Even Earnings for Q2
PetMeds (PETS) to Advance Pet Care With New Collaboration
PETS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PetMed (PETS) Reports Break-Even Earnings for Q1
Implied Volatility Surging for PetMed Express (PETS) Stock Options
Time for Pet ETF on Upbeat Earnings from Chewy? (Revised)
Other News for PETS
Noteworthy Monday Option Activity: PETS, FDX, TTWO
PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
PetMed: Fiscal Q3 Earnings Snapshot
PetMedsĀ®Ā Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement